Buy Strides Arcolab from a long term perspective: Sonam Udasi

Sonam Udasi, Head of Research, IDBI Capital in an interview with ET Now talks about pharma stocks.

What is the call on Strides Arcolab?

Currently in the pharma space whatever is to do with the CRAM space will be lumpy and it is really news driven what they are going to do. In the generic space, it is slightly more cash flow. So if you have a long term, go for stocks like Strides Arcolab even Aurobindo Pharma after that huge correction we saw but that said if you have a shorter term view, it could be very volatile for these stocks.